the effect of combined herbal capsule on covid-19 disease
Phase 3
Recruiting
- Conditions
- Covid-19 disease.
- Registration Number
- IRCT20210804052068N1
- Lead Sponsor
- Shooshtar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients admitted to covid-19 wards of the hospital
positive pcr test
Age range 20 to 70 years
Willingness to participate in the study
Exclusion Criteria
The patient avoids taking the capsule
changing the type and amount of medication taken during the intervention
Any changes in treatment plan and disease conditions
Chronic diseases such as diabetes, hypertension, cancer, obesity (body mass index above 30)
History of drug and food allergies
Transfer the patient to the intensive care unit
??? ????? ?? ????? ?????? ?? ??????
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Age, history of disease, history of use of immunosuppressive drugs, sex, level of education, length of hospital stay, economic status, blood lipids, blood interleukins, hs-CRP. Timepoint: From the first of November 2021to the first of July 2022. Method of measurement: the studied markers are measured by spectrophotometric and ELISA methods.
- Secondary Outcome Measures
Name Time Method